首页 › 黄斑变性 › 得克萨斯州 › The Woodlands
The Woodlands TX 黄斑变性临床试验
9项针对 黄斑变性的研究正在 The Woodlands及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
招募中2/3 期
- Retina Consultants of Texas (Site 014), The Woodlands
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
招募中2/3 期
- Retina Consultants of Texas, The Woodlands
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
招募中3 期
- Retina Consultants Texas, The Woodlands
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
招募中2 期
- Retina Consultants of Texas, The Woodlands
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
招募中1 期
- Retina Consultants Texas, The Woodlands
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
招募中2 期
- Adverum site 107, The Woodlands
- Adverum site 231, The Woodlands
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
招募中1/2 期
- Retina Consultants - The Woodlands /ID# 262138, The Woodlands
Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration
招募中1/2 期
- The Woodlands, TX, The Woodlands
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
招募中观察性研究欢迎健康志愿者
- Retina Consultants of Texas (Houston), The Woodlands
其他城市的 黄斑变性试验
- Dallas, TX13 项研究
- Erie, PA10 项研究
- Reno, NV8 项研究
- Hagerstown, MD8 项研究
- Sacramento, CA8 项研究
- Fort Worth, TX7 项研究
- Cleveland, OH7 项研究
- Houston, TX7 项研究
- Austin, TX7 项研究
- Salt Lake City, UT7 项研究
- Carmel, IN7 项研究
- Phoenix, AZ7 项研究
The Woodlands的其他研究
- 非小细胞肺癌15 项研究
- 肥胖症12 项研究
- 超重10 项研究
- 乳腺癌10 项研究
- 心血管疾病9 项研究
- 转移性癌症9 项研究
- 2型糖尿病7 项研究
- 心力衰竭7 项研究
- 肺癌7 项研究
- 动脉粥样硬化6 项研究
- 地图样萎缩6 项研究
- 前列腺癌6 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。